Year: 2024
Type: review
Abstract: In addition to the recognized types of multiple endocrine neoplasia (MEN) syndromes (MEN 1, MEN 2a, and MEN 2b), MEN 4 was described relatively recently, and there is now a proposition of a fifth variety.It has been recognized as an independent syndrome by the 5th edition of the WHO Classification of Endocrine and Neuroendocrine Tumors as well as the 5th edition of the Genetic Tumor Syndromes.Multiple endocrine neoplasia type 5 (MEN 5) is caused by a pathogenic mutation in MYC associated factor X (MAX) gene, which is a tumor suppressor gene.The endocrine manifestations include tumors of the adrenal, pituitary, parathyroid, and pancreas.The non-endocrine tumors include renal cell carcinoma, renal oncocytoma, and carcinoma of the lung.This article thoroughly reviews the available literature and tries to understand the journey of discovery of a new syndrome in endocrine surgery.
Authors: Sunil Chumber, Gopal Puri, Kanika Sharma, Reva S Sahu, Piyush Ranjan, Brijesh K Singh
Institution: All India Institute of Medical Sciences
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4405698291